# Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT

> **NCT04118556** · PHASE2 · TERMINATED · sponsor: **Mats Remberger** · enrollment: 12 (actual)

## Conditions studied

- GVHD, Acute

## Interventions

- **BIOLOGICAL:** Decidua Stroma Cells (DSC)
- **DRUG:** Best available Treatment (BAT)

## Key facts

- **NCT ID:** NCT04118556
- **Lead sponsor:** Mats Remberger
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-12-01
- **Primary completion:** 2026-04-29
- **Final completion:** 2026-04-29
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Too slow recruitment
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04118556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04118556, "Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT04118556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*